ID   ATPA_HUMAN              Reviewed;         553 AA.
AC   P25705; A8K092; B4DY56; K7ENP3; Q53XX6; Q8IXV2; Q96FB4; Q96HW2;
AC   Q96IR6; Q9BTV8;
DT   01-MAY-1992, integrated into UniProtKB/Swiss-Prot.
DT   01-MAY-1992, sequence version 1.
DT   10-MAY-2017, entry version 205.
DE   RecName: Full=ATP synthase subunit alpha, mitochondrial;
DE   Flags: Precursor;
GN   Name=ATP5A1; Synonyms=ATP5A, ATP5AL2, ATPM;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1).
RC   TISSUE=Lung tumor;
RX   PubMed=1830491; DOI=10.1016/0167-4781(91)90183-M;
RA   Kataoka H., Biswas C.;
RT   "Nucleotide sequence of a cDNA for the alpha subunit of human
RT   mitochondrial ATP synthase.";
RL   Biochim. Biophys. Acta 1089:393-395(1991).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1), AND TISSUE SPECIFICITY.
RC   TISSUE=Retinoblastoma;
RX   PubMed=8428659; DOI=10.1016/0378-1119(93)90124-L;
RA   Godbout R., Bisgrove D.A., Honore L.H., Day R.S. III;
RT   "Amplification of the gene encoding the alpha-subunit of the
RT   mitochondrial ATP synthase complex in a human retinoblastoma cell
RT   line.";
RL   Gene 123:195-201(1993).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA / MRNA] (ISOFORM 1).
RC   TISSUE=Colon tumor;
RX   PubMed=8086450; DOI=10.1016/0167-4781(94)90255-0;
RA   Akiyama S., Endo H., Inohara N., Ohta S., Kagawa Y.;
RT   "Gene structure and cell type-specific expression of the human ATP
RT   synthase alpha subunit.";
RL   Biochim. Biophys. Acta 1219:129-140(1994).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1).
RA   Kalnine N., Chen X., Rolfs A., Halleck A., Hines L., Eisenstein S.,
RA   Koundinya M., Raphael J., Moreira D., Kelley T., LaBaer J., Lin Y.,
RA   Phelan M., Farmer A.;
RT   "Cloning of human full-length CDSs in BD Creator(TM) system donor
RT   vector.";
RL   Submitted (MAY-2003) to the EMBL/GenBank/DDBJ databases.
RN   [5]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORMS 2 AND 3).
RC   TISSUE=Small intestine, and Testis;
RX   PubMed=14702039; DOI=10.1038/ng1285;
RA   Ota T., Suzuki Y., Nishikawa T., Otsuki T., Sugiyama T., Irie R.,
RA   Wakamatsu A., Hayashi K., Sato H., Nagai K., Kimura K., Makita H.,
RA   Sekine M., Obayashi M., Nishi T., Shibahara T., Tanaka T., Ishii S.,
RA   Yamamoto J., Saito K., Kawai Y., Isono Y., Nakamura Y., Nagahari K.,
RA   Murakami K., Yasuda T., Iwayanagi T., Wagatsuma M., Shiratori A.,
RA   Sudo H., Hosoiri T., Kaku Y., Kodaira H., Kondo H., Sugawara M.,
RA   Takahashi M., Kanda K., Yokoi T., Furuya T., Kikkawa E., Omura Y.,
RA   Abe K., Kamihara K., Katsuta N., Sato K., Tanikawa M., Yamazaki M.,
RA   Ninomiya K., Ishibashi T., Yamashita H., Murakawa K., Fujimori K.,
RA   Tanai H., Kimata M., Watanabe M., Hiraoka S., Chiba Y., Ishida S.,
RA   Ono Y., Takiguchi S., Watanabe S., Yosida M., Hotuta T., Kusano J.,
RA   Kanehori K., Takahashi-Fujii A., Hara H., Tanase T.-O., Nomura Y.,
RA   Togiya S., Komai F., Hara R., Takeuchi K., Arita M., Imose N.,
RA   Musashino K., Yuuki H., Oshima A., Sasaki N., Aotsuka S.,
RA   Yoshikawa Y., Matsunawa H., Ichihara T., Shiohata N., Sano S.,
RA   Moriya S., Momiyama H., Satoh N., Takami S., Terashima Y., Suzuki O.,
RA   Nakagawa S., Senoh A., Mizoguchi H., Goto Y., Shimizu F., Wakebe H.,
RA   Hishigaki H., Watanabe T., Sugiyama A., Takemoto M., Kawakami B.,
RA   Yamazaki M., Watanabe K., Kumagai A., Itakura S., Fukuzumi Y.,
RA   Fujimori Y., Komiyama M., Tashiro H., Tanigami A., Fujiwara T.,
RA   Ono T., Yamada K., Fujii Y., Ozaki K., Hirao M., Ohmori Y.,
RA   Kawabata A., Hikiji T., Kobatake N., Inagaki H., Ikema Y., Okamoto S.,
RA   Okitani R., Kawakami T., Noguchi S., Itoh T., Shigeta K., Senba T.,
RA   Matsumura K., Nakajima Y., Mizuno T., Morinaga M., Sasaki M.,
RA   Togashi T., Oyama M., Hata H., Watanabe M., Komatsu T.,
RA   Mizushima-Sugano J., Satoh T., Shirai Y., Takahashi Y., Nakagawa K.,
RA   Okumura K., Nagase T., Nomura N., Kikuchi H., Masuho Y., Yamashita R.,
RA   Nakai K., Yada T., Nakamura Y., Ohara O., Isogai T., Sugano S.;
RT   "Complete sequencing and characterization of 21,243 full-length human
RT   cDNAs.";
RL   Nat. Genet. 36:40-45(2004).
RN   [6]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=16177791; DOI=10.1038/nature03983;
RA   Nusbaum C., Zody M.C., Borowsky M.L., Kamal M., Kodira C.D.,
RA   Taylor T.D., Whittaker C.A., Chang J.L., Cuomo C.A., Dewar K.,
RA   FitzGerald M.G., Yang X., Abouelleil A., Allen N.R., Anderson S.,
RA   Bloom T., Bugalter B., Butler J., Cook A., DeCaprio D., Engels R.,
RA   Garber M., Gnirke A., Hafez N., Hall J.L., Norman C.H., Itoh T.,
RA   Jaffe D.B., Kuroki Y., Lehoczky J., Lui A., Macdonald P., Mauceli E.,
RA   Mikkelsen T.S., Naylor J.W., Nicol R., Nguyen C., Noguchi H.,
RA   O'Leary S.B., Piqani B., Smith C.L., Talamas J.A., Topham K.,
RA   Totoki Y., Toyoda A., Wain H.M., Young S.K., Zeng Q., Zimmer A.R.,
RA   Fujiyama A., Hattori M., Birren B.W., Sakaki Y., Lander E.S.;
RT   "DNA sequence and analysis of human chromosome 18.";
RL   Nature 437:551-555(2005).
RN   [7]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1).
RC   TISSUE=Lung, Retina, and Uterus;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA
RT   project: the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [8]
RP   PROTEIN SEQUENCE [LARGE SCALE ANALYSIS] OF 44-59.
RC   TISSUE=Leukemic T-cell;
RX   PubMed=19892738; DOI=10.1073/pnas.0908958106;
RA   Xu G., Shin S.B., Jaffrey S.R.;
RT   "Global profiling of protease cleavage sites by chemoselective
RT   labeling of protein N-termini.";
RL   Proc. Natl. Acad. Sci. U.S.A. 106:19310-19315(2009).
RN   [9]
RP   PROTEIN SEQUENCE OF 46-83; 89-103; 134-161; 176-182; 219-230; 242-252;
RP   306-316; 335-347; 403-416; 435-463 AND 507-527, AND IDENTIFICATION BY
RP   MASS SPECTROMETRY.
RC   TISSUE=Brain, Cajal-Retzius cell, and Fetal brain cortex;
RA   Lubec G., Vishwanath V., Chen W.-Q., Sun Y.;
RL   Submitted (DEC-2008) to UniProtKB.
RN   [10]
RP   PROTEIN SEQUENCE OF 46-73; 104-123; 134-161; 219-230; 232-239;
RP   306-316; 335-347; 403-416; 442-463 AND 507-527, AND IDENTIFICATION BY
RP   MASS SPECTROMETRY.
RC   TISSUE=B-cell lymphoma;
RA   Bienvenut W.V.;
RL   Submitted (MAR-2005) to UniProtKB.
RN   [11]
RP   PROTEIN SEQUENCE OF 134-141 AND 335-339.
RC   TISSUE=Heart;
RX   PubMed=7498159; DOI=10.1002/elps.11501601192;
RA   Kovalyov L.I., Shishkin S.S., Efimochkin A.S., Kovalyova M.A.,
RA   Ershova E.S., Egorov T.A., Musalyamov A.K.;
RT   "The major protein expression profile and two-dimensional protein
RT   database of human heart.";
RL   Electrophoresis 16:1160-1169(1995).
RN   [12]
RP   INTERACTION WITH PLG, IDENTIFICATION BY MASS SPECTROMETRY, SUBCELLULAR
RP   LOCATION, AND FUNCTION.
RX   PubMed=10077593; DOI=10.1073/pnas.96.6.2811;
RA   Moser T.L., Stack M.S., Asplin I., Enghild J.J., Hojrup P.,
RA   Everitt L., Hubchak S., Schnaper H.W., Pizzo S.V.;
RT   "Angiostatin binds ATP synthase on the surface of human endothelial
RT   cells.";
RL   Proc. Natl. Acad. Sci. U.S.A. 96:2811-2816(1999).
RN   [13]
RP   INTERACTION WITH ATPAF2.
RX   PubMed=11410595; DOI=10.1074/jbc.M104133200;
RA   Wang Z.-G., White P.S., Ackerman S.H.;
RT   "Atp11p and Atp12p are assembly factors for the F(1)-ATPase in human
RT   mitochondria.";
RL   J. Biol. Chem. 276:30773-30778(2001).
RN   [14]
RP   INTERACTION WITH HRG, IDENTIFICATION BY MASS SPECTROMETRY, SUBCELLULAR
RP   LOCATION, AND FUNCTION.
RX   PubMed=19285951; DOI=10.1016/j.bbamem.2009.03.005;
RA   Ohta T., Ikemoto Y., Usami A., Koide T., Wakabayashi S.;
RT   "High affinity interaction between histidine-rich glycoprotein and the
RT   cell surface type ATP synthase on T-cells.";
RL   Biochim. Biophys. Acta 1788:1099-1107(2009).
RN   [15]
RP   ACETYLATION [LARGE SCALE ANALYSIS] AT LYS-161; LYS-261; LYS-434;
RP   LYS-498; LYS-506 AND LYS-539, AND IDENTIFICATION BY MASS SPECTROMETRY
RP   [LARGE SCALE ANALYSIS].
RX   PubMed=19608861; DOI=10.1126/science.1175371;
RA   Choudhary C., Kumar C., Gnad F., Nielsen M.L., Rehman M.,
RA   Walther T.C., Olsen J.V., Mann M.;
RT   "Lysine acetylation targets protein complexes and co-regulates major
RT   cellular functions.";
RL   Science 325:834-840(2009).
RN   [16]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=21269460; DOI=10.1186/1752-0509-5-17;
RA   Burkard T.R., Planyavsky M., Kaupe I., Breitwieser F.P.,
RA   Buerckstuemmer T., Bennett K.L., Superti-Furga G., Colinge J.;
RT   "Initial characterization of the human central proteome.";
RL   BMC Syst. Biol. 5:17-17(2011).
RN   [17]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-166, AND IDENTIFICATION
RP   BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=21406692; DOI=10.1126/scisignal.2001570;
RA   Rigbolt K.T., Prokhorova T.A., Akimov V., Henningsen J.,
RA   Johansen P.T., Kratchmarova I., Kassem M., Mann M., Olsen J.V.,
RA   Blagoev B.;
RT   "System-wide temporal characterization of the proteome and
RT   phosphoproteome of human embryonic stem cell differentiation.";
RL   Sci. Signal. 4:RS3-RS3(2011).
RN   [18]
RP   INTERACTION WITH BLOC1S1, AND ACETYLATION.
RX   PubMed=22309213; DOI=10.1042/BJ20120118;
RA   Scott I., Webster B.R., Li J.H., Sack M.N.;
RT   "Identification of a molecular component of the mitochondrial acetyl
RT   transferase program; a novel role for GCN5L1.";
RL   Biochem. J. 443:655-661(2012).
RN   [19]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-53; SER-65; SER-76;
RP   SER-166 AND SER-184, AND IDENTIFICATION BY MASS SPECTROMETRY [LARGE
RP   SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma, and Erythroleukemia;
RX   PubMed=23186163; DOI=10.1021/pr300630k;
RA   Zhou H., Di Palma S., Preisinger C., Peng M., Polat A.N., Heck A.J.,
RA   Mohammed S.;
RT   "Toward a comprehensive characterization of a human cancer cell
RT   phosphoproteome.";
RL   J. Proteome Res. 12:260-271(2013).
RN   [20]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-76, AND IDENTIFICATION
RP   BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Liver;
RX   PubMed=24275569; DOI=10.1016/j.jprot.2013.11.014;
RA   Bian Y., Song C., Cheng K., Dong M., Wang F., Huang J., Sun D.,
RA   Wang L., Ye M., Zou H.;
RT   "An enzyme assisted RP-RPLC approach for in-depth analysis of human
RT   liver phosphoproteome.";
RL   J. Proteomics 96:253-262(2014).
RN   [21]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=25944712; DOI=10.1002/pmic.201400617;
RA   Vaca Jacome A.S., Rabilloud T., Schaeffer-Reiss C., Rompais M.,
RA   Ayoub D., Lane L., Bairoch A., Van Dorsselaer A., Carapito C.;
RT   "N-terminome analysis of the human mitochondrial proteome.";
RL   Proteomics 15:2519-2524(2015).
RN   [22]
RP   VARIANT MC5DN4 CYS-329.
RX   PubMed=23599390; DOI=10.1093/brain/awt086;
RA   Jonckheere A.I., Renkema G.H., Bras M., van den Heuvel L.P.,
RA   Hoischen A., Gilissen C., Nabuurs S.B., Huynen M.A., de Vries M.C.,
RA   Smeitink J.A., Rodenburg R.J.;
RT   "A complex V ATP5A1 defect causes fatal neonatal mitochondrial
RT   encephalopathy.";
RL   Brain 136:1544-1554(2013).
RN   [23]
RP   VARIANT COXPD22 CYS-321, CHARACTERIZATION OF VARIANT COXPD22 CYS-321,
RP   AND INVOLVEMENT IN COXPD22.
RX   PubMed=23596069; DOI=10.1212/WNL.0b013e3182918c40;
RA   Lieber D.S., Calvo S.E., Shanahan K., Slate N.G., Liu S.,
RA   Hershman S.G., Gold N.B., Chapman B.A., Thorburn D.R., Berry G.T.,
RA   Schmahmann J.D., Borowsky M.L., Mueller D.M., Sims K.B., Mootha V.K.;
RT   "Targeted exome sequencing of suspected mitochondrial disorders.";
RL   Neurology 80:1762-1770(2013).
CC   -!- FUNCTION: Mitochondrial membrane ATP synthase (F(1)F(0) ATP
CC       synthase or Complex V) produces ATP from ADP in the presence of a
CC       proton gradient across the membrane which is generated by electron
CC       transport complexes of the respiratory chain. F-type ATPases
CC       consist of two structural domains, F(1) - containing the
CC       extramembraneous catalytic core, and F(0) - containing the
CC       membrane proton channel, linked together by a central stalk and a
CC       peripheral stalk. During catalysis, ATP synthesis in the catalytic
CC       domain of F(1) is coupled via a rotary mechanism of the central
CC       stalk subunits to proton translocation. Subunits alpha and beta
CC       form the catalytic core in F(1). Rotation of the central stalk
CC       against the surrounding alpha(3)beta(3) subunits leads to
CC       hydrolysis of ATP in three separate catalytic sites on the beta
CC       subunits. Subunit alpha does not bear the catalytic high-affinity
CC       ATP-binding sites (By similarity). {ECO:0000250,
CC       ECO:0000269|PubMed:10077593, ECO:0000269|PubMed:19285951}.
CC   -!- SUBUNIT: F-type ATPases have 2 components, CF(1) - the catalytic
CC       core - and CF(0) - the membrane proton channel. CF(1) has five
CC       subunits: alpha(3), beta(3), gamma(1), delta(1), epsilon(1). CF(0)
CC       has three main subunits: a, b and c. Interacts with ATPAF2
CC       (PubMed:11410595). Interacts with HRG; the interaction occurs on
CC       the surface of T-cells and alters the cell morphology when
CC       associated with concanavalin (in vitro) (PubMed:19285951).
CC       Interacts with PLG (angiostatin peptide); the interaction inhibits
CC       most of the angiogenic properties of angiostatin
CC       (PubMed:10077593). Component of an ATP synthase complex composed
CC       of ATP5F1, ATP5G1, ATP5E, ATP5H, ATP5I, ATP5J, ATP5J2, MT-ATP6,
CC       MT-ATP8, ATP5A1, ATP5B, ATP5D, ATP5C1, ATP5O, ATP5L, USMG5 and
CC       MP68. Interacts with BLOC1S1 (PubMed:22309213). Interacts with
CC       BCL2L1 isoform BCL-X(L); the interaction mediates the association
CC       of BCL2L1 isoform BCL-X(L) with the mitochondrial membrane
CC       F(1)F(0) ATP synthase and enhances neurons metabolic efficency.
CC       Interacts with CLN5 and PPT1 (By similarity).
CC       {ECO:0000250|UniProtKB:Q03265, ECO:0000269|PubMed:10077593,
CC       ECO:0000269|PubMed:11410595, ECO:0000269|PubMed:19285951,
CC       ECO:0000269|PubMed:22309213}.
CC   -!- INTERACTION:
CC       P78537:BLOC1S1; NbExp=2; IntAct=EBI-351437, EBI-348630;
CC       Q9NTG7:SIRT3; NbExp=2; IntAct=EBI-351437, EBI-724621;
CC       P63104:YWHAZ; NbExp=3; IntAct=EBI-351437, EBI-347088;
CC   -!- SUBCELLULAR LOCATION: Mitochondrion inner membrane {ECO:0000305}.
CC       Cell membrane; Peripheral membrane protein; Extracellular side
CC       {ECO:0000269|PubMed:10077593}. Note=Colocalizes with HRG on the
CC       cell surface of T-cells (PubMed:19285951).
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=3;
CC       Name=1;
CC         IsoId=P25705-1; Sequence=Displayed;
CC       Name=2;
CC         IsoId=P25705-2; Sequence=VSP_045129;
CC       Name=3;
CC         IsoId=P25705-3; Sequence=VSP_054688;
CC         Note=No experimental confirmation available.;
CC   -!- TISSUE SPECIFICITY: Fetal lung, heart, liver, gut and kidney.
CC       Expressed at higher levels in the fetal brain, retina and spinal
CC       cord. {ECO:0000269|PubMed:8428659}.
CC   -!- PTM: The N-terminus is blocked.
CC   -!- PTM: Acetylated on lysine residues. BLOC1S1 is required for
CC       acetylation. {ECO:0000269|PubMed:22309213}.
CC   -!- DISEASE: Combined oxidative phosphorylation deficiency 22
CC       (COXPD22) [MIM:616045]: A mitochondrial disorder characterized by
CC       intrauterine growth retardation, microcephaly, hypotonia,
CC       pulmonary hypertension, failure to thrive, encephalopathy, and
CC       heart failure. {ECO:0000269|PubMed:23596069}. Note=The disease is
CC       caused by mutations affecting the gene represented in this entry.
CC   -!- DISEASE: Mitochondrial complex V deficiency, nuclear 4 (MC5DN4)
CC       [MIM:615228]: A mitochondrial disorder with heterogeneous clinical
CC       manifestations including dysmorphic features, psychomotor
CC       retardation, hypotonia, growth retardation, cardiomyopathy,
CC       enlarged liver, hypoplastic kidneys and elevated lactate levels in
CC       urine, plasma and cerebrospinal fluid.
CC       {ECO:0000269|PubMed:23599390}. Note=The disease is caused by
CC       mutations affecting the gene represented in this entry.
CC   -!- SIMILARITY: Belongs to the ATPase alpha/beta chains family.
CC       {ECO:0000305}.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; X59066; CAA41789.1; -; mRNA.
DR   EMBL; X65460; CAA46452.1; -; mRNA.
DR   EMBL; D14710; BAA03531.1; -; mRNA.
DR   EMBL; D28126; BAA05672.1; -; Genomic_DNA.
DR   EMBL; BT007209; AAP35873.1; -; mRNA.
DR   EMBL; AK092735; BAG52604.1; -; mRNA.
DR   EMBL; AK289457; BAF82146.1; -; mRNA.
DR   EMBL; AK302272; BAG63618.1; -; mRNA.
DR   EMBL; AC012569; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; BC003119; AAH03119.1; -; mRNA.
DR   EMBL; BC007299; AAH07299.1; -; mRNA.
DR   EMBL; BC008028; AAH08028.2; -; mRNA.
DR   EMBL; BC011384; AAH11384.1; -; mRNA.
DR   EMBL; BC016046; AAH16046.1; -; mRNA.
DR   EMBL; BC019310; AAH19310.1; -; mRNA.
DR   EMBL; BC039135; AAH39135.2; -; mRNA.
DR   EMBL; BC064562; AAH64562.1; -; mRNA.
DR   EMBL; BC067385; AAH67385.1; -; mRNA.
DR   CCDS; CCDS11927.1; -. [P25705-1]
DR   CCDS; CCDS58620.1; -. [P25705-2]
DR   CCDS; CCDS59315.1; -. [P25705-3]
DR   PIR; S17193; PWHUA.
DR   RefSeq; NP_001001935.1; NM_001001935.2. [P25705-2]
DR   RefSeq; NP_001001937.1; NM_001001937.1. [P25705-1]
DR   RefSeq; NP_001244263.1; NM_001257334.1. [P25705-3]
DR   RefSeq; NP_001244264.1; NM_001257335.1. [P25705-2]
DR   RefSeq; NP_004037.1; NM_004046.5. [P25705-1]
DR   UniGene; Hs.298280; -.
DR   ProteinModelPortal; P25705; -.
DR   SMR; P25705; -.
DR   BioGrid; 106987; 169.
DR   DIP; DIP-32871N; -.
DR   IntAct; P25705; 61.
DR   MINT; MINT-1163289; -.
DR   STRING; 9606.ENSP00000282050; -.
DR   ChEMBL; CHEMBL2062351; -.
DR   DrugBank; DB07384; 1-ACETYL-2-CARBOXYPIPERIDINE.
DR   DrugBank; DB07394; AUROVERTIN B.
DR   DrugBank; DB08399; PICEATANNOL.
DR   DrugBank; DB04216; Quercetin.
DR   iPTMnet; P25705; -.
DR   PhosphoSitePlus; P25705; -.
DR   SwissPalm; P25705; -.
DR   BioMuta; ATP5A1; -.
DR   DMDM; 114517; -.
DR   OGP; P25705; -.
DR   REPRODUCTION-2DPAGE; P25705; -.
DR   UCD-2DPAGE; P25705; -.
DR   EPD; P25705; -.
DR   PaxDb; P25705; -.
DR   PeptideAtlas; P25705; -.
DR   PRIDE; P25705; -.
DR   TopDownProteomics; P25705-1; -. [P25705-1]
DR   DNASU; 498; -.
DR   Ensembl; ENST00000282050; ENSP00000282050; ENSG00000152234. [P25705-1]
DR   Ensembl; ENST00000398752; ENSP00000381736; ENSG00000152234. [P25705-1]
DR   Ensembl; ENST00000590665; ENSP00000467037; ENSG00000152234. [P25705-3]
DR   Ensembl; ENST00000593152; ENSP00000465477; ENSG00000152234. [P25705-2]
DR   GeneID; 498; -.
DR   KEGG; hsa:498; -.
DR   UCSC; uc010dnl.2; human. [P25705-1]
DR   CTD; 498; -.
DR   DisGeNET; 498; -.
DR   GeneCards; ATP5A1; -.
DR   HGNC; HGNC:823; ATP5A1.
DR   HPA; CAB013067; -.
DR   HPA; HPA040622; -.
DR   HPA; HPA044202; -.
DR   MalaCards; ATP5A1; -.
DR   MIM; 164360; gene.
DR   MIM; 615228; phenotype.
DR   MIM; 616045; phenotype.
DR   neXtProt; NX_P25705; -.
DR   OpenTargets; ENSG00000152234; -.
DR   Orphanet; 254913; Isolated ATP synthase deficiency.
DR   PharmGKB; PA25115; -.
DR   eggNOG; KOG1353; Eukaryota.
DR   eggNOG; COG0056; LUCA.
DR   GeneTree; ENSGT00550000074846; -.
DR   HOVERGEN; HBG001536; -.
DR   InParanoid; P25705; -.
DR   KO; K02132; -.
DR   OMA; KRFNEAQ; -.
DR   OrthoDB; EOG091G0D1M; -.
DR   PhylomeDB; P25705; -.
DR   TreeFam; TF300321; -.
DR   Reactome; R-HSA-1268020; Mitochondrial protein import.
DR   Reactome; R-HSA-163210; Formation of ATP by chemiosmotic coupling.
DR   ChiTaRS; ATP5A1; human.
DR   GenomeRNAi; 498; -.
DR   PMAP-CutDB; P25705; -.
DR   PRO; PR:P25705; -.
DR   Proteomes; UP000005640; Chromosome 18.
DR   Bgee; ENSG00000152234; -.
DR   CleanEx; HS_ATP5A1; -.
DR   ExpressionAtlas; P25705; baseline and differential.
DR   Genevisible; P25705; HS.
DR   GO; GO:0070062; C:extracellular exosome; IDA:UniProtKB.
DR   GO; GO:0031012; C:extracellular matrix; IDA:BHF-UCL.
DR   GO; GO:0016020; C:membrane; IDA:UniProtKB.
DR   GO; GO:0005743; C:mitochondrial inner membrane; IDA:UniProtKB.
DR   GO; GO:0005759; C:mitochondrial matrix; TAS:Reactome.
DR   GO; GO:0005753; C:mitochondrial proton-transporting ATP synthase complex; IDA:UniProtKB.
DR   GO; GO:0005739; C:mitochondrion; IDA:UniProtKB.
DR   GO; GO:0043209; C:myelin sheath; IEA:Ensembl.
DR   GO; GO:0005886; C:plasma membrane; IDA:UniProtKB.
DR   GO; GO:0045259; C:proton-transporting ATP synthase complex; IDA:CAFA.
DR   GO; GO:0045261; C:proton-transporting ATP synthase complex, catalytic core F(1); IEA:UniProtKB-KW.
DR   GO; GO:0043532; F:angiostatin binding; IPI:CAFA.
DR   GO; GO:0005524; F:ATP binding; ISS:UniProtKB.
DR   GO; GO:0042288; F:MHC class I protein binding; IDA:UniProtKB.
DR   GO; GO:0046933; F:proton-transporting ATP synthase activity, rotational mechanism; IMP:CAFA.
DR   GO; GO:0003723; F:RNA binding; IDA:UniProtKB.
DR   GO; GO:0022857; F:transmembrane transporter activity; IC:UniProtKB.
DR   GO; GO:0006754; P:ATP biosynthetic process; IMP:CAFA.
DR   GO; GO:0009790; P:embryo development; ISS:UniProtKB.
DR   GO; GO:0006629; P:lipid metabolic process; ISS:UniProtKB.
DR   GO; GO:0042776; P:mitochondrial ATP synthesis coupled proton transport; TAS:Reactome.
DR   GO; GO:0001937; P:negative regulation of endothelial cell proliferation; IMP:UniProtKB.
DR   GO; GO:0043536; P:positive regulation of blood vessel endothelial cell migration; IGI:CAFA.
DR   CDD; cd01132; F1_ATPase_alpha; 1.
DR   Gene3D; 2.40.30.20; -; 1.
DR   HAMAP; MF_01346; ATP_synth_alpha_bact; 1.
DR   InterPro; IPR023366; ATP_synth_asu-like.
DR   InterPro; IPR000793; ATP_synth_asu_C.
DR   InterPro; IPR033732; ATP_synth_F1_a.
DR   InterPro; IPR005294; ATP_synth_F1_asu.
DR   InterPro; IPR020003; ATPase_a/bsu_AS.
DR   InterPro; IPR004100; ATPase_F1/V1/A1_a/bsu_N.
DR   InterPro; IPR000194; ATPase_F1/V1/A1_a/bsu_nucl-bd.
DR   InterPro; IPR027417; P-loop_NTPase.
DR   Pfam; PF00006; ATP-synt_ab; 1.
DR   Pfam; PF00306; ATP-synt_ab_C; 1.
DR   Pfam; PF02874; ATP-synt_ab_N; 1.
DR   PIRSF; PIRSF039088; F_ATPase_subunit_alpha; 1.
DR   SUPFAM; SSF50615; SSF50615; 1.
DR   SUPFAM; SSF52540; SSF52540; 1.
DR   TIGRFAMs; TIGR00962; atpA; 1.
DR   PROSITE; PS00152; ATPASE_ALPHA_BETA; 1.
PE   1: Evidence at protein level;
KW   Acetylation; Alternative splicing; ATP synthesis; ATP-binding;
KW   Cell membrane; CF(1); Complete proteome; Direct protein sequencing;
KW   Disease mutation; Glycoprotein; Hydrogen ion transport; Ion transport;
KW   Membrane; Methylation; Mitochondrion; Mitochondrion inner membrane;
KW   Nucleotide-binding; Phosphoprotein; Polymorphism;
KW   Pyrrolidone carboxylic acid; Reference proteome; Transit peptide;
KW   Transport.
FT   TRANSIT       1     43       Mitochondrion.
FT                                {ECO:0000269|PubMed:19892738}.
FT   CHAIN        44    553       ATP synthase subunit alpha,
FT                                mitochondrial.
FT                                /FTId=PRO_0000002424.
FT   NP_BIND     212    219       ATP. {ECO:0000250}.
FT   SITE        413    413       Required for activity. {ECO:0000250}.
FT   MOD_RES      44     44       Pyrrolidone carboxylic acid.
FT                                {ECO:0000250|UniProtKB:P19483}.
FT   MOD_RES      53     53       Phosphoserine.
FT                                {ECO:0000244|PubMed:23186163}.
FT   MOD_RES      65     65       Phosphoserine.
FT                                {ECO:0000244|PubMed:23186163}.
FT   MOD_RES      76     76       Phosphoserine; alternate.
FT                                {ECO:0000244|PubMed:23186163,
FT                                ECO:0000244|PubMed:24275569}.
FT   MOD_RES     106    106       Phosphoserine.
FT                                {ECO:0000250|UniProtKB:Q03265}.
FT   MOD_RES     123    123       N6-acetyllysine.
FT                                {ECO:0000250|UniProtKB:Q03265}.
FT   MOD_RES     126    126       N6-acetyllysine.
FT                                {ECO:0000250|UniProtKB:Q03265}.
FT   MOD_RES     132    132       N6-acetyllysine.
FT                                {ECO:0000250|UniProtKB:Q03265}.
FT   MOD_RES     134    134       Phosphothreonine.
FT                                {ECO:0000250|UniProtKB:P15999}.
FT   MOD_RES     161    161       N6-acetyllysine; alternate.
FT                                {ECO:0000244|PubMed:19608861}.
FT   MOD_RES     161    161       N6-succinyllysine; alternate.
FT                                {ECO:0000250|UniProtKB:Q03265}.
FT   MOD_RES     166    166       Phosphoserine.
FT                                {ECO:0000244|PubMed:21406692,
FT                                ECO:0000244|PubMed:23186163}.
FT   MOD_RES     167    167       N6-acetyllysine; alternate.
FT                                {ECO:0000250|UniProtKB:Q03265}.
FT   MOD_RES     167    167       N6-succinyllysine; alternate.
FT                                {ECO:0000250|UniProtKB:Q03265}.
FT   MOD_RES     184    184       Phosphoserine.
FT                                {ECO:0000244|PubMed:23186163}.
FT   MOD_RES     204    204       Omega-N-methylarginine.
FT                                {ECO:0000250|UniProtKB:Q03265}.
FT   MOD_RES     230    230       N6-acetyllysine; alternate.
FT                                {ECO:0000250|UniProtKB:Q03265}.
FT   MOD_RES     230    230       N6-succinyllysine; alternate.
FT                                {ECO:0000250|UniProtKB:Q03265}.
FT   MOD_RES     239    239       N6-acetyllysine; alternate.
FT                                {ECO:0000250|UniProtKB:Q03265}.
FT   MOD_RES     239    239       N6-succinyllysine; alternate.
FT                                {ECO:0000250|UniProtKB:Q03265}.
FT   MOD_RES     240    240       N6-acetyllysine.
FT                                {ECO:0000250|UniProtKB:Q03265}.
FT   MOD_RES     261    261       N6-acetyllysine; alternate.
FT                                {ECO:0000244|PubMed:19608861}.
FT   MOD_RES     261    261       N6-succinyllysine; alternate.
FT                                {ECO:0000250|UniProtKB:Q03265}.
FT   MOD_RES     305    305       N6-acetyllysine; alternate.
FT                                {ECO:0000250|UniProtKB:Q03265}.
FT   MOD_RES     305    305       N6-succinyllysine; alternate.
FT                                {ECO:0000250|UniProtKB:Q03265}.
FT   MOD_RES     427    427       N6-acetyllysine; alternate.
FT                                {ECO:0000250|UniProtKB:Q03265}.
FT   MOD_RES     427    427       N6-succinyllysine; alternate.
FT                                {ECO:0000250|UniProtKB:Q03265}.
FT   MOD_RES     434    434       N6-acetyllysine.
FT                                {ECO:0000244|PubMed:19608861}.
FT   MOD_RES     498    498       N6-acetyllysine; alternate.
FT                                {ECO:0000244|PubMed:19608861}.
FT   MOD_RES     498    498       N6-succinyllysine; alternate.
FT                                {ECO:0000250|UniProtKB:Q03265}.
FT   MOD_RES     506    506       N6-acetyllysine; alternate.
FT                                {ECO:0000244|PubMed:19608861}.
FT   MOD_RES     506    506       N6-succinyllysine; alternate.
FT                                {ECO:0000250|UniProtKB:Q03265}.
FT   MOD_RES     531    531       N6-acetyllysine; alternate.
FT                                {ECO:0000250|UniProtKB:Q03265}.
FT   MOD_RES     531    531       N6-succinyllysine; alternate.
FT                                {ECO:0000250|UniProtKB:Q03265}.
FT   MOD_RES     539    539       N6-acetyllysine; alternate.
FT                                {ECO:0000244|PubMed:19608861}.
FT   MOD_RES     539    539       N6-succinyllysine; alternate.
FT                                {ECO:0000250|UniProtKB:Q03265}.
FT   MOD_RES     541    541       N6-acetyllysine.
FT                                {ECO:0000250|UniProtKB:Q03265}.
FT   CARBOHYD     76     76       O-linked (GlcNAc) serine; alternate.
FT                                {ECO:0000250}.
FT   VAR_SEQ       1     50       Missing (in isoform 2).
FT                                {ECO:0000303|PubMed:14702039}.
FT                                /FTId=VSP_045129.
FT   VAR_SEQ     140    161       Missing (in isoform 3).
FT                                {ECO:0000303|PubMed:14702039}.
FT                                /FTId=VSP_054688.
FT   VARIANT      32     32       A -> S (in dbSNP:rs2228437).
FT                                /FTId=VAR_048369.
FT   VARIANT     223    223       I -> V (in dbSNP:rs2228436).
FT                                /FTId=VAR_048370.
FT   VARIANT     321    321       Y -> C (in COXPD22; reduces mitochondrial
FT                                membrane potential; dbSNP:rs587777788).
FT                                {ECO:0000269|PubMed:23596069}.
FT                                /FTId=VAR_071982.
FT   VARIANT     329    329       R -> C (in MC5DN4; dbSNP:rs587776960).
FT                                {ECO:0000269|PubMed:23599390}.
FT                                /FTId=VAR_069769.
FT   CONFLICT    162    162       G -> V (in Ref. 5; BAG63618).
FT                                {ECO:0000305}.
FT   CONFLICT    183    183       I -> T (in Ref. 5; BAG63618).
FT                                {ECO:0000305}.
FT   CONFLICT    329    329       R -> L (in Ref. 5; AAH39135).
FT                                {ECO:0000305}.
FT   CONFLICT    356    356       N -> D (in Ref. 5; BAG63618).
FT                                {ECO:0000305}.
FT   CONFLICT    510    510       A -> D (in Ref. 5; AAH11384).
FT                                {ECO:0000305}.
FT   CONFLICT    529    529       D -> E (in Ref. 5; AAH11384).
FT                                {ECO:0000305}.
SQ   SEQUENCE   553 AA;  59751 MW;  AA47BBB8EDA77EAC CRC64;
     MLSVRVAAAV VRALPRRAGL VSRNALGSSF IAARNFHASN THLQKTGTAE MSSILEERIL
     GADTSVDLEE TGRVLSIGDG IARVHGLRNV QAEEMVEFSS GLKGMSLNLE PDNVGVVVFG
     NDKLIKEGDI VKRTGAIVDV PVGEELLGRV VDALGNAIDG KGPIGSKTRR RVGLKAPGII
     PRISVREPMQ TGIKAVDSLV PIGRGQRELI IGDRQTGKTS IAIDTIINQK RFNDGSDEKK
     KLYCIYVAIG QKRSTVAQLV KRLTDADAMK YTIVVSATAS DAAPLQYLAP YSGCSMGEYF
     RDNGKHALII YDDLSKQAVA YRQMSLLLRR PPGREAYPGD VFYLHSRLLE RAAKMNDAFG
     GGSLTALPVI ETQAGDVSAY IPTNVISITD GQIFLETELF YKGIRPAINV GLSVSRVGSA
     AQTRAMKQVA GTMKLELAQY REVAAFAQFG SDLDAATQQL LSRGVRLTEL LKQGQYSPMA
     IEEQVAVIYA GVRGYLDKLE PSKITKFENA FLSHVVSQHQ ALLGTIRADG KISEQSDAKL
     KEIVTNFLAG FEA
//
